title: Comment on 'Anti-tumour activity of abiraterone and diethylstilboestrol when administered sequentially to men with castration-resistant prostate cancer'.
authors.affiliation: St Bartholomew's Hospital, 7th Floor, Gloucester House, Little Britain, UK.
authors.forename: J
authors.initials: J
authors.lastname: Shamash
authors.affiliation: Centre for Experimental Cancer Medicine, Queen Mary University of London, London, UK.
authors.forename: S-J
authors.initials: SJ
authors.lastname: Sarker
mesh_terms: D000737:Androstenols / Q000627:therapeutic use*; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D004054:Diethylstilbestrol / Q000627:therapeutic use*; D004968:Estrogens, Non-Steroidal / Q000627:therapeutic use*; D006801:Humans; D008297:Male; D011471:Prostatic Neoplasms / Q000188:drug therapy*; D013254:Steroid 17-alpha-Hydroxylase / Q000037:antagonists & inhibitors*
chemical_list: D000737:Androstenols; D004968:Estrogens, Non-Steroidal; D004054:Diethylstilbestrol; D013254:Steroid 17-alpha-Hydroxylase